Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2001 1
2010 1
2011 1
2017 1
2019 2
2020 1
2021 2
2022 1
2024 1
2025 2
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean elisa monzon (18 results)?
Molecular diagnosis of primary CNS lymphoma in 2024 using MYD88Leu265Pro and IL-10.
Calimeri T, Anzalone N, Cangi MG, Fiore P, Gagliardi F, Miserocchi E, Ponzoni M, Ferreri AJM. Calimeri T, et al. Lancet Haematol. 2024 Jul;11(7):e540-e549. doi: 10.1016/S2352-3026(24)00104-2. Lancet Haematol. 2024. PMID: 38937027 Review.
By contrast, the MYD88(Leu265Pro) somatic hotspot mutation, revealed by PCR-based assay, is currently and reliably used during the diagnosis of some lymphomas, and IL-10, measured by enzyme-linked immunosorbent assay, is routinely used to diagno …
By contrast, the MYD88(Leu265Pro) somatic hotspot mutation, revealed by PCR-based assay, is currently and reliably used during the di …
Biomarkers for an early diagnosis of immune effector cell associated-hemophagocytic syndrome.
Campodonico E, Angelillo P, Doglio M, Ugolini A, Lupo Stanghellini MT, Noviello M, Tassi E, Pedica F, Bergonzi GM, Lazzari L, Bruno A, Diral E, Ponzoni M, Corti C, Peccatori J, Ruggeri A, Ferreri AJM, Bonini C, Ciceri F, Carrabba MG, Greco R. Campodonico E, et al. Front Immunol. 2025 Aug 14;16:1635062. doi: 10.3389/fimmu.2025.1635062. eCollection 2025. Front Immunol. 2025. PMID: 40895549 Free PMC article.
We selected a set of acute-phase molecules including CD163, IL33R (quantitated through ELISA), CTLA-4, and CD80 (quantitated through Luminex) and studied their trend in frozen sera collected at parallel time-points. ...
We selected a set of acute-phase molecules including CD163, IL33R (quantitated through ELISA), CTLA-4, and CD80 (quantitated through …
Inhibition of neuroblastoma-induced angiogenesis by fenretinide.
Ribatti D, Alessandri G, Baronio M, Raffaghello L, Cosimo E, Marimpietri D, Montaldo PG, De Falco G, Caruso A, Vacca A, Ponzoni M. Ribatti D, et al. Int J Cancer. 2001 Nov 1;94(3):314-21. doi: 10.1002/ijc.1441. Int J Cancer. 2001. PMID: 11745408
The effects of HPR on certain endothelial cell functions were investigated in vitro, and its effects on angiogenesis was studied in vivo, by using the chorioallantoic membrane (CAM) assay. HPR inhibited vascular endothelial growth factor- (VEGF-) and fibroblast growth fact …
The effects of HPR on certain endothelial cell functions were investigated in vitro, and its effects on angiogenesis was studied in vivo, by …
Calreticulin as a novel B-cell receptor antigen in chronic lymphocytic leukemia.
ten Hacken E, Gounari M, Back JW, Shimanovskaya E, Scarfò L, Kim E, Burks J, Ponzoni M, Ramirez GA, Wierda WG, Estrov Z, Keating MJ, Ferrajoli A, Stamatopoulos K, Ghia P, Burger JA. ten Hacken E, et al. Haematologica. 2017 Oct;102(10):e394-e396. doi: 10.3324/haematol.2017.169102. Epub 2017 Jul 27. Haematologica. 2017. PMID: 28751563 Free PMC article. No abstract available.
B lymphocytes directly contribute to tissue fibrosis in patients with IgG4-related disease.
Della-Torre E, Rigamonti E, Perugino C, Baghai-Sain S, Sun N, Kaneko N, Maehara T, Rovati L, Ponzoni M, Milani R, Lanzillotta M, Mahajan V, Mattoo H, Molineris I, Deshpande V, Stone JH, Falconi M, Manfredi AA, Pillai S. Della-Torre E, et al. J Allergy Clin Immunol. 2020 Mar;145(3):968-981.e14. doi: 10.1016/j.jaci.2019.07.004. Epub 2019 Jul 15. J Allergy Clin Immunol. 2020. PMID: 31319101 Free PMC article.
Profibrotic soluble factors and collagen production in cocultures were assessed by using ELISAs and Luminex assays. RNA sequencing and quantitative RT-PCR were used to assess fibroblast activation in the presence of B cells, as well as induction of profibrotic pathways in …
Profibrotic soluble factors and collagen production in cocultures were assessed by using ELISAs and Luminex assays. RNA sequencing an …
Evaluation of the immediate effects of a single transcranial direct current stimulation session on astrocyte activation, inflammatory response, and pain threshold in naïve rats.
Callai EMM, Zin LEF, Catarina LS, Ponzoni D, Gonçalves CAS, Vizuete AFK, Cougo MC, Boff J, Puricelli E, Fernandes EK, da Silva Torres IL, Quevedo AS. Callai EMM, et al. Behav Brain Res. 2022 Jun 25;428:113880. doi: 10.1016/j.bbr.2022.113880. Epub 2022 Apr 4. Behav Brain Res. 2022. PMID: 35390432
A second experiment (n = 16) was performed using a similar protocol to test the hypotheses that S100B levels in the cerebrospinal fluid (CSF) are altered by tDCS. Elisa assay quantified the levels of tumor necrosis factor-alfa (TNF-alpha), interleukin-10 (IL10), S10 …
A second experiment (n = 16) was performed using a similar protocol to test the hypotheses that S100B levels in the cerebrospinal fluid (CSF …
L19-Conjugated Gold Nanoparticles for the Specific Targeting of EDB-Containing Fibronectin in Neuroblastoma.
Barisione C, Ortona S, Bensa V, Ivaldo C, Ciampi E, Astigiano S, Cilli M, Zardi L, Ponzoni M, Palombo D, Pratesi G, Ferrari PF, Pastorino F. Barisione C, et al. Pharmaceutics. 2025 Dec 24;18(1):24. doi: 10.3390/pharmaceutics18010024. Pharmaceutics. 2025. PMID: 41599131 Free PMC article.
A gold nanoparticle, decorated with an antibody (Ab) recognizing FN-EDB (L19-AuNP) was developed by the company Nano Flow and its tumor binding was tested by ELISA in vitro and in patient-derived xenograft (PDX) models of NB by photoacoustic imaging in vivo. ...
A gold nanoparticle, decorated with an antibody (Ab) recognizing FN-EDB (L19-AuNP) was developed by the company Nano Flow and its tumor bind …
MYD88 L265P mutation and interleukin-10 detection in cerebrospinal fluid are highly specific discriminating markers in patients with primary central nervous system lymphoma: results from a prospective study.
Ferreri AJM, Calimeri T, Lopedote P, Francaviglia I, Daverio R, Iacona C, Belloni C, Steffanoni S, Gulino A, Anghileri E, Diffidenti A, Finardi A, Gagliardi F, Anzalone N, Nonis A, Furlan R, De Lorenzo D, Terreni MR, Martinelli V, Sassone M, Foppoli M, Angelillo P, Guggiari E, Falini A, Mortini P, Filippi M, Tarantino V, Eoli M, Ciceri F, Doglioni C, Tripodo C, Locatelli M, Cangi MG, Ponzoni M. Ferreri AJM, et al. Br J Haematol. 2021 May;193(3):497-505. doi: 10.1111/bjh.17357. Epub 2021 Feb 23. Br J Haematol. 2021. PMID: 33620087 Free article. Clinical Trial.
IL-6 and IL-10 messenger RNA (mRNA) was assessed on PCNSL biopsies using RNAscope technology. IL levels in CSF were assessed by enzyme-linked immunosorbent assay. Mut-MYD88 was detected in 15/17 (88%) PCNSL biopsies, with an 82% concordance in paired t …
IL-6 and IL-10 messenger RNA (mRNA) was assessed on PCNSL biopsies using RNAscope technology. IL levels in CSF were assessed by enzyme …
Preclinical evaluation of the first intravenous small molecule MDM2 antagonist alone and in combination with temozolomide in neuroblastoma.
Chen L, Pastorino F, Berry P, Bonner J, Kirk C, Wood KM, Thomas HD, Zhao Y, Daga A, Veal GJ, Lunec J, Newell DR, Ponzoni M, Tweddle DA. Chen L, et al. Int J Cancer. 2019 Jun 15;144(12):3146-3159. doi: 10.1002/ijc.32058. Epub 2019 Jan 9. Int J Cancer. 2019. PMID: 30536898 Free PMC article.
Detection of active idasanutlin using liquid chromatography-mass spectrometry and p53 pathway activation by ELISA assays and Western analysis showed peak plasma levels 1 h post-treatment with maximal p53 pathway activation 3-6 h post-treatment. ...
Detection of active idasanutlin using liquid chromatography-mass spectrometry and p53 pathway activation by ELISA assays and Western …
13 results